8,517 articles
Daniel Catovsky
Daniel Catovsky (1937–2022) was an Argentine-born British haematologist who defined the diagnosis and treatment of chronic lymphocytic leukemia, working at the Royal Marsden Hospital and Institute of Cancer Research in London.
Daniel Cattran
Daniel C. Cattran is a Canadian nephrologist and University of Toronto professor who chairs the Toronto Glomerulonephritis Registry and co-led the MENTOR trial establishing rituximab for membranous nephropathy.
Daniel Chandramohan
Daniel Chandramohan is a clinical epidemiologist and Professor of Public Health at the London School of Hygiene & Tropical Medicine, known for leading large malaria vaccine trials in West Africa.
Daniel D. Von Hoff
Daniel D. Von Hoff is an American medical oncologist and Distinguished Professor at TGen in Phoenix, Arizona, known for developing new anticancer agents, especially for pancreatic cancer.
Daniel De Backer
Daniel De Backer (born 1961) is a Belgian intensivist, professor at the Université Libre de Bruxelles, who led the SOAP II trial and was ESICM president from 2014 to 2016.
Daniel De Carvalho
Daniel De Carvalho is a cancer epigenetics researcher at the Princess Margaret Cancer Centre and University of Toronto, known for viral mimicry and the cfMeDIP-seq blood test.
Daniel Deykin
Daniel Deykin is an American physician and researcher who trained in Boston and directed VA health services research, best known for his reviews of warfarin and heparin therapy.
Daniel E. Furst
Daniel E. Furst is an American rheumatologist and clinical pharmacologist, professor emeritus at UCLA, who pioneered placebo-controlled systemic sclerosis trials and helped develop rheumatoid arthritis response criteria.
Daniel E. Goldberg
Daniel E. Goldberg is an American malaria parasitologist and physician-scientist at Washington University in St. Louis whose work on Plasmodium falciparum protein export identified antimalarial drug targets.
Daniel E. Lieberman
Daniel E. Lieberman, born 1964, is an American paleoanthropologist and evolutionary biologist at Harvard, known for the endurance running hypothesis, the evolution of the human head, and barefoot running research.
Daniel E. Neafsey
Daniel E. Neafsey is a malaria genomics researcher at the Harvard Chan School of Public Health and the Broad Institute, known for genetic analyses of the RTS,S malaria vaccine.
Daniel E. Singer
Daniel E. Singer is an American physician-scientist at Massachusetts General Hospital and Harvard whose research on anticoagulation in atrial fibrillation set the standard INR target range.
Daniel F. Hanley
Daniel F. Hanley, also published as Daniel Hanley, is an American neurologist at Johns Hopkins who leads large randomized clinical trials in brain injury, intracerebral hemorrhage, and COVID-19 convalescent plasma.
Daniel F. Hayes
Daniel F. Hayes is an American medical oncologist and breast cancer biomarker researcher at the University of Michigan, and was President of ASCO from 2016 to 2017.
Daniel F. McAuley
Daniel F. McAuley is a Professor of Intensive Care Medicine at Queen's University Belfast and the Royal Victoria Hospital, known for precision-medicine research in acute respiratory distress syndrome.
Daniel Friedman (American neurologist)
Daniel Friedman is an American neurologist and epileptologist, Professor of Neurology at NYU Grossman School of Medicine, who directs the Division of Epilepsy at NYU Langone and researches cannabinoids, seizure-detection wearables, and SUDEP.
Daniel G. Bichet
Daniel G. Bichet is a Canadian nephrologist at the Hôpital du Sacré-Cœur de Montréal and Université de Montréal, first to identify the AVPR2 gene behind nephrogenic diabetes insipidus.
Daniel G. Tenen
Daniel G. Tenen is a hematologist-oncologist and cancer researcher, Professor of Medicine at Harvard Medical School in Boston, known for work on PU.1, C/EBPα, and SALL4 in leukemia.
Daniel Gaudet
Daniel Gaudet is a Canadian lipidologist, associate professor of medicine at the Université de Montréal, and head of ECOGENE-21, known internationally for trials of APOC3-targeting drugs that lower triglycerides.
Daniel H. Lowenstein
Daniel H. Lowenstein is an American neurologist and epileptologist at the University of California, San Francisco, known for research on status epilepticus, large-scale epilepsy genetics programs, and medical education reform.
Daniel H. Solomon
Daniel H. Solomon is a rheumatologist and pharmacoepidemiologist at Brigham and Women's Hospital in Boston, a Harvard Medical School professor known for research on cardiovascular risk in rheumatoid arthritis.
Daniel Hunt
Daniel P. Hunt is an American hospitalist and professor of medicine directing the Division of Hospital Medicine at Emory, known for New England Journal of Medicine clinicopathologic case conferences.
Daniel I. Sessler
Daniel I. Sessler is an American anesthesiologist and perioperative outcomes researcher whose trials showed mild hypothermia during surgery raises wound-infection risk, making warming standard practice.
Daniel J. Drucker
Daniel J. Drucker (born 1956) is a Canadian endocrinologist and diabetes researcher at the University of Toronto whose work on the GLP-1 and GLP-2 hormones underlies major type 2 diabetes and obesity drugs.
Daniel J. Lovell
Daniel J. Lovell is an American pediatric rheumatologist at Cincinnati Children's Hospital, known for pivotal trials of biologic therapies in juvenile idiopathic arthritis published from 2000 to 2012.
Daniel J. Rader
Daniel J. Rader is an American physician-scientist in human genetics and lipid metabolism at the University of Pennsylvania, chair of its Department of Genetics since 2014.
Daniel J. Sargent
Daniel J. Sargent, also known as Daniel Sargent, was an American biostatistician at Mayo Clinic who designed cancer clinical trials until his death in 2016.
Daniel J. Siegwart
Daniel J. Siegwart is a biochemist and nanomedicine researcher at UT Southwestern Medical Center who developed SORT lipid nanoparticles for tissue-specific mRNA delivery and CRISPR gene editing.
Daniel Kaul
Daniel R. Kaul is an American infectious diseases physician and Clinical Professor at the University of Michigan who directs the Transplant Infectious Disease Service and studies donor-derived infections.
Daniel Kraft (physician-scientist)
Daniel Kraft is an American physician-scientist, inventor, and entrepreneur trained at Brown, Stanford, and Harvard, known for "exponential medicine," the MarrowMiner device, and founding NextMed Health.